Antimicrobial Peptide for Atopic Dermatitis via Membrane Disruption
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current antimicrobial peptides lack efficient antibacterial and immunological activity simultaneously, and existing treatments for atopic dermatitis are inadequate in providing both antibacterial and immunomodulatory effects.
Innovation Solution
A novel peptide with the amino acid sequence SEQ ID NO: 1, which exhibits both strong antibacterial activity against gram-negative and gram-positive bacteria and immunoregulatory functions, is used as an active ingredient in antibacterial agents, pharmaceutical compositions for treating atopic dermatitis, and cosmetic compositions for skin amelioration.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional antibiotics are used to inhibit microbial growth, then antibacterial activity is achieved, but microorganisms develop resistance over time
Solution Approach 1:
The peptide is designed with distinct functional segments: a positively charged hydrophilic moiety (residues 1-3: Lys-Lys-Phe) that binds to negatively charged bacterial membranes, and a hydrophobic moiety (residues 4-7: Trp-Tyr-Arg-Dmt) that inserts into the membrane to form pores. This segmentation allows the peptide to physically disrupt bacterial cells rather than relying on enzymatic inhibition, preventing resistance development.
Solution Approach 2:
The peptide utilizes specific physicochemical parameters including amphipathic structure, net positive charge (+2 at physiological pH), and hydrophobicity to achieve membrane disruption. These parameter changes enable the peptide to physically destroy bacterial cells through pore formation, a mechanism that bacteria cannot develop resistance against through conventional genetic adaptation.
2Productivity
If antimicrobial peptides with strong antibacterial activity are designed, then bacterial killing efficiency is improved, but immunological activity and anti-inflammatory effects are reduced
Solution Approach 1:
The peptide achieves multi-functionality by simultaneously exhibiting potent antibacterial activity against both Gram-positive and Gram-negative bacteria, as well as immunomodulatory effects through FPR2 receptor activation. This universal activity profile allows a single peptide structure to address multiple therapeutic needs: direct pathogen elimination and regulation of host immune responses, including reduction of inflammatory cytokines (IL-6, IL-8, TNF-α) and induction of anti-inflammatory cytokines (IL-10).
3Reliability
If existing treatments for atopic dermatitis are used, then skin symptoms are managed, but both antibacterial and immunomodulatory effects are insufficient
Solution Approach 1:
The peptide merges previously separate therapeutic functions into a single molecule: antibacterial defense, anti-inflammatory action, and immunoregulation. This combining of functions addresses the multifactorial nature of atopic dermatitis, which involves both bacterial colonization (Staphylococcus aureus) and dysregulated immune responses, by providing simultaneous treatment for both aspects through one agent.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The peptide demonstrates high antimicrobial efficacy against various bacteria and effectively ameliorates atopic dermatitis symptoms by regulating immune responses, making it suitable for use in both antibiotic and cosmetic applications.
Implementation Method 1
after the positively-charged hydrophilic moiety binds to the negatively-charged cell membrane of bacteria
Implementation Method 2
the hydrophobic moiety of the peptide bound to the cell membrane interacts with the hydrophobic moiety of the phospholipid of the cell membrane and forms pores on the cell membrane
Implementation Method 3
FPR2 is known to play an important role in inflammatory diseases. Activation of FPR2 induces the separation of the Gβγ subunit from the Gαi subunit and the βγ-subunit induces the activation of phospholipase Cβ or phosphoinositide 3-kinase
Data Source
Figure 1
Figure 2A~2B
Figure 3
AI summary
The present invention relates to a novel peptide having both an antimicrobial effect and an immunocyte activity regulatory function, and a use thereof. The peptide of the present invention regulates immunocyte activity and also exhibits antimicrobial activity against various bacteria such as gram-negative bacteria and gram-positive bacteria, thereby being useful for treating various immune diseases such as atopic dermatitis and for treating diseases caused by the infection of pathogenic bacteria.